
Contribution to the understanding of Pseudomonas aeruginosa virulence in search of innovative therapeutic approaches
Cellular and Molecular Pharmacology
Promotors : F. Van Bambeke and M.P. Mingeot-Leclercq
related publications:
- Anantharajah et al. Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1-beta secretion in a model of human THP-1 monocytes. FEMS Pathogens and Disease (2015) 73:ftv049.
- Anantharajah et al. Inhibition of the injectisome and flagellar type III secretion systems by INP1855 impairs Pseudomonas aeruginosa pathogenicity and inflammasome activation. Journal of Infectious Diseases (2016) 214:1105-1116
- Anantharajah et al. Salicylidene acylhydrazides and hydroxyquinolines act as inhibitors of type three secretion systems in Pseudomonas aeruginosa by distinct mechanisms. Antimicrobial Agents and Chemotherapy (2017), in press
- Anantharajah et al. Targeting Type Three Secretion System in Pseudomonas aeruginosa. Trends in Pharmacological Sciences (2016) 37:734-749